“…EVRs are reported to occur in up to 6% of patients receiving intravenous cancer chemotherapy ( Bertelli, 1995 , Cassagnol and McBride, 2009 ). Indeed, HN2 exhibits a very complex mechanism of toxicity that involves many macromolecules and cell signaling pathways ( Korkmaz et al, 2006 , McManus and Huebner, 2005 , Tewari-Singh and Agarwal, 2016 ). Our group previously reported that HN2 triggers numerous responses in cultured skin cells in vitro , including damaged nuclear DNA, increased lipid peroxidation and apoptosis via activation of caspases 3 and 9 ( Lulla et al, 2013 , Pino and Billack, 2008 , Pino et al, 2014 ), and that the organoselenium compound ebselen (EB-1) reduces the toxicity of both HN2 ( Hardej and Billack, 2007 , Lulla et al, 2014 ) and the sulfur half mustard CEES in vitro ( Pino et al, 2013 ).…”